Atlas · Hip

Levator Ani

Levator ani is a group of pelvic-floor muscles involved in support, continence and coordinated relaxation for bowel and bladder function. Persistent pelvic, perineal or rectal pain may include muscle tenderness or difficulty relaxing, often alongside another pelvic condition. Care starts with an appropriate medical and pelvic-floor assessment.

Body region

Hip

Trigger points

documented in this muscle

Common symptoms

patterns cataloged

Contributors

Factors to assess

Muscle overview

Symptoms and first steps

Practical first steps

Practice comfortable unforced breathing with the abdomen and pelvic floor allowed to soften; do not bear down or strain to initiate urination.
Break prolonged sitting with a comfortable change of position and use support that reduces the familiar pressure.
Discuss constipation and bladder symptoms with the relevant clinician; avoid repeated stop-start urination as an exercise.

When to seek assessment

Acute severe pelvic pain, sudden inability to pass urine, or heavy rectal/vaginal bleeding needs emergency assessment. Fever, other difficulty emptying the bladder, other unexplained rectal/vaginal bleeding, or pain with possible pregnancy needs urgent medical assessment.
New saddle numbness, progressive leg weakness or loss of bladder/bowel control needs emergency assessment.
Persistent painful urination, visible blood in urine, cyclical pelvic pain, bowel change or unexplained weight loss warrants medical evaluation without waiting for a fixed self-care period.

Assess the ability to relax as well as to contract. A painful, overactive pelvic floor may need coordination and relaxation work before strengthening; repeated Kegels are not a universal response to pelvic pain.

Examination, palpation and treatment evidence

Illustrated overview

Levator Ani · Anatomy 1. Anatomical view of the illustrated muscle. — **Levator Ani · Anatomy 1**
Anatomical view of the illustrated muscle.
Open full-size image

Trigger points

Select a trigger point

1. Levator Ani

Location. Levator ani complex within the pelvic floor; internal localization requires an explicitly consented specialist examination

Trigger point map

Map not available

Referred pain map

Map not available

Pain referral. Pelvic floor, perineum

Pain Pattern

Pelvic floor
Perineum
Lower pelvis

What This Pain Feels Like

A deep pelvic or rectal ache, pressure or sitting intolerance can coexist with tender pelvic-floor muscles. Symptoms during bowel movements, urination or sexual activity should be described specifically and assessed for muscle, organ and neural contributions.

What Patients Report

A deep pelvic or rectal ache
Perineal discomfort with prolonged sitting
Pain with a particular bowel, bladder or sexual activity

What Makes It Worse

Prolonged sitting in some people
Bowel movements or sexual activity in some presentations
Sustained involuntary pelvic-floor contraction

Browse related exercises (1)

Symptoms patients report

Pelvic, perineal or rectal aching Describe the duration, location and relation to sitting, bowel movements, urination and sexual activity rather than using one general pelvic-issues label.

Difficulty relaxing or painful muscle contraction The clinician may find tenderness and incomplete relaxation; these findings can coexist with weakness and do not mandate more strengthening.

Bowel, bladder or sexual symptoms Constipation, urgency, painful penetration or ejaculation need their own assessment and can coexist with pelvic-floor myalgia.

Contributors to assess

Persistent guarding around pelvic pain Muscle guarding can become part of a continuing pain presentation without proving that it started the condition.

Constipation, childbirth, surgery or prior injury The relevance of each history depends on current findings; childbirth does not automatically establish muscle overactivity.

Sustained sitting and symptom-related avoidance These can alter activity tolerance. Tailor changes to the actual trigger and keep comfortable activities available.

For clinicians and supervised training

Clinical reference

Muscle tenderness neither confirms the sole cause of pelvic pain nor excludes endometriosis, bladder pain syndrome, infection or bowel disease. An internal examination is an optional, explicitly consented clinician examination.

Anatomy and palpation

Anatomical relationships

Levator ani comprises puborectalis, pubococcygeus and iliococcygeus. Puborectalis forms a sling around the anorectal junction; the broader components extend from the pubis and the tendinous arch on obturator fascia toward midline pelvic structures, the anococcygeal region and coccyx.[1]

The pubis and ischial spines orient internal anatomy; they are not self-pressure targets.
The tendinous arch lies on obturator internus fascia along the lateral pelvic wall.
The puborectalis sling surrounds the anorectal junction; component boundaries vary.

Nearby structures. Rectum, anal sphincters, urethra and sex-specific pelvic organs are adjacent. Obturator internus forms part of the lateral pelvic wall, coccygeus lies posteriorly, and pudendal neurovascular structures are nearby.

Palpation

Patient position. A trained pelvic-health clinician offers external assessment first. If an internal vaginal or rectal examination is indicated, explain its purpose and alternatives, obtain explicit consent, agree a stop signal and offer a chaperone; use the position the patient can tolerate.

Find the landmarks

External perineal and pelvic landmarks orient the examination.
Internal levator regions are localized only within a trained, consented examination, separately from obturator internus and the anal sphincters.

Examination sequence

Review bowel, bladder, sexual and medical symptoms before muscle testing.
Observe comfortable breathing and, with consent, external pelvic-floor movement; ask for a gentle contraction followed by full release.
If the patient accepts an internal examination, use gentle contact to document region-specific tenderness, recognizable pain and contraction/relaxation. Stop on request or when the examination is not tolerable.

Document the findings

Document tenderness and familiar pain separately from resting tone, contraction strength and ability to relax.
A tender levator on a clinician rectal examination can support levator ani syndrome after other causes of chronic anal pain have been excluded.

Limits and precautions

Declining or stopping internal assessment must not prevent access to external care or medical investigation.
Do not teach deep self-palpation, forceful release, urination-straining or an automatic strengthening prescription.

[2][4]

Examination and tests

Pelvic-floor contraction and relaxation assessment[2][3]

Distinguish strength, coordination and relaxation problems that need different treatment.

Position: Supported supine or side lying; external observation or a separately consented clinician internal examination.
Technique: Ask for a comfortable gentle lift/contraction, then a complete release while breathing normally. Compare baseline resting behavior with the ability to return to it; document pain, substitution with buttocks/abdomen and delayed release. Use biofeedback when clinically appropriate and acceptable.
Positive finding: Familiar pain, limited contraction or incomplete relaxation after the effort.
Interpretation: Select coordination/relaxation work for impaired release; strengthening may be added when weakness is relevant and contraction is tolerable.
Limitations: Neither subjective tightness nor measured tone alone explains all pelvic pain. Never test by repeatedly stopping urine flow.

Consented chronic anal-pain assessment[2][4]

Evaluate a possible levator ani syndrome and identify bowel or anorectal conditions needing different care.

Position: Clinician-directed assessment, usually side lying for a rectal examination only after explanation and explicit consent.
Technique: Review episode duration, bowel pattern and alarm symptoms. The clinician assesses anorectal disease and, if appropriate, gently examines levator/puborectalis tenderness. When evacuation dysfunction is suspected, arrange anorectal physiology or balloon-expulsion testing rather than asking the patient to strain as a home test.
Positive finding: Reproduction of the usual ache with levator traction in a compatible chronic anal-pain presentation, or impaired evacuation on formal testing.
Interpretation: The tender-levator subgroup is the population in which biofeedback showed the clearest trial benefit.
Limitations: A muscle examination does not exclude fissure, inflammatory bowel disease, malignancy or other pelvic disease. Internal testing may be declined or deferred.

Distinguishing other causes

Bladder pain syndrome, urinary infection or prostate-related pain[2]

Findings that matter. Pain linked to bladder filling/voiding, urgency, dysuria, fever or ejaculatory symptoms.

Next step. Medical evaluation and urine testing or urological assessment as indicated; pelvic muscle care may be concurrent.

Endometriosis or other gynecological disease[2]

Findings that matter. Cyclical pain, abnormal bleeding, deep dyspareunia, pregnancy possibility or other pelvic-organ symptoms.

Next step. Gynecological assessment and targeted investigation. Pelvic-floor physiotherapy cannot by itself rule these conditions out.

Anorectal disease or evacuation disorder[2][4]

Findings that matter. Bleeding, fissure-like pain, persistent constipation, tenesmus or a changed bowel pattern.

Next step. Assess bowel/anorectal causes and use physiology testing when warranted; tailor biofeedback to an identified disorder.

Pudendal or other neurological pain[2]

Findings that matter. Burning/electric perineal pain, altered sensation or a positional neural pattern; sudden saddle sensory loss is urgent.

Next step. Neurological and pelvic-pain assessment; do not assume a tender levator confirms nerve entrapment.

Treatment selection and progression

Self-care and activity

Pelvic-floor relaxation and bowel/bladder coordination[3]

Consider when. A clinician-assessed difficulty relaxing, with the relevant organ and neurological causes considered.

Use comfortable unforced breathing in a supported position and practice releasing unnecessary abdominal, gluteal and pelvic-floor contraction. Coordinate constipation management and toileting advice with the treating clinician; avoid bearing down to start urination.

Dose and review: Brief comfortable practice matched to symptoms; there is no universal number of sessions or contractions.
Progression: Apply relaxation during the daily task that provokes guarding; add strength only if examination identifies a need.
Stop or reassess: Stop a technique that increases pressure, pain or urinary difficulty and review it with the clinician.
Evidence and limits: Specialist pelvic-pain guidance supports individualized relaxation/coordination care, with a broader treatment plan.

Clinician-delivered care

Biofeedback for a confirmed levator/evacuation presentation[4]

Consider when. Chronic anal pain with levator tenderness or a documented pelvic-floor evacuation/relaxation problem.

A trained clinician uses feedback to teach relaxation and coordinated evacuation. Agree whether internal sensors or testing are acceptable and choose alternatives when needed.

Dose and review: The biofeedback arm used five weekly 30-minute training sessions followed by four counselling sessions: nine visits in total. The clinical course is individualized, not a promise that pelvic pain resolves in that number.
Progression: Review pain days, bowel function and meaningful activities; continue when the learned coordination is transferring into daily life.
Stop or reassess: Reassess for new bleeding, new bowel change, increasing pain or inability to tolerate the treatment.
Evidence and limits: In a 157-person randomized trial, biofeedback outperformed stimulation and massage in the tender-levator subgroup, with improvement maintained to 12 months. Those without examination tenderness did not show the same benefit.

Clinician-delivered care

Pelvic myofascial physiotherapy for a tender pelvic floor[5]

Consider when. Pelvic-floor tenderness accompanying assessed bladder-pain syndrome; a pelvic-health examination determines whether local manual treatment fits the broader presentation.

A pelvic-health clinician selects external pelvic, hip or abdominal soft-tissue work and, only with explicit ongoing consent, internal techniques where examined levator tenderness is relevant. Include relaxation and graded activity. Internal contact is optional; keep organ-specific assessment and treatment in place.

Dose and review: The trial offered up to ten 60-minute sessions over 12 weeks. Use this as a studied reference, with dose adjusted to consent, tolerance and measurable benefit; an external-only adaptation has not been shown equivalent to the full trial program.
Progression: Follow overall symptom response and a chosen goal such as sitting or wanted sexual activity. Reassess benefit at the end of the agreed course rather than treating residual tenderness indefinitely.
Stop or reassess: Stop any unwanted or intolerable technique immediately. New unexplained bleeding, infection symptoms or sustained symptom worsening require clinical reassessment.
Evidence and limits: Among 81 women with bladder pain for no longer than three years and pelvic-floor tenderness, targeted internal/external myofascial physiotherapy produced 59% global responders versus 26% with global massage at 12 weeks. Separate pain, urgency and frequency changes did not significantly differ. The regional program does not prove isolated pelvic-muscle efficacy or cure bladder disease.

Clinician-delivered care

Levator-directed injection for selected persistent myalgia[6][7]

Consider when. Focal, reproducible levator-related pain that remains disabling after an appropriate assessment and discussion of conservative options.

A pelvic-pain specialist reviews the target, injectate, expected benefit and procedure risks. The injection is based on the examination, not the Atlas marker; agree on an activity and review point before proceeding.

Dose and review: No needle depth, drug dose or fixed repeat schedule is prescribed here. Review the first treatment before considering another.
Progression: Assess pain and the chosen activity within the first month and include pelvic-floor rehabilitation if useful.
Stop or reassess: After a procedure, increasing severe pelvic pain, sudden inability to pass urine, new saddle numbness, progressive leg weakness or loss of bladder/bowel control needs emergency assessment. Fever or other new urinary or neurological symptoms needs urgent clinical advice.
Evidence and limits: A pilot trial with 29 completers found similar pain improvement with injections or physiotherapy one month after treatment; physiotherapy favored sexual-function change. No sham arm and small groups limit confidence. A separate 94-woman placebo trial did not show better primary pain outcomes from pelvic Botox through 26 weeks, so reduced tone alone is not a reason for routine toxin treatment.

Clinician-delivered care

Specialist botulinum toxin for selected persistent pelvic-floor spasm[8][7]

Consider when. Persistent painful pelvic-floor spasm confirmed on specialist examination despite tailored physiotherapy and treatment of contributing conditions; evidence is most directly applicable to a selected endometriosis-associated population.

Discuss botulinum toxin with a pelvic-pain specialist after reviewing prior care, the examination target, alternatives and procedure risks. Set a patient-selected pain or daily-function goal and continue useful pelvic-floor rehabilitation.

Dose and review: The specialist chooses the formulation and procedure; this page does not prescribe a dose or repeat schedule.
Progression: Review the individual pain or function response before considering further injections. A change in resting muscle activity alone is insufficient.
Stop or reassess: Review worsening pain, urinary or bowel effects, or unwanted weakness; new urinary retention or severe symptoms after the procedure require prompt assessment.
Evidence and limits: A 2026 phase 2 placebo-controlled trial in 29 participants with endometriosis-associated pain and pelvic-floor spasm favored toxin for patient-reported benefit at one month. This small selected population differs from a 94-woman trial of broader chronic pelvic pain that did not show superior primary pain outcomes through 26 weeks. Longer-term open-label responses do not establish durable comparative benefit.

Reassessment and follow-up

Track the patient-selected outcome: sitting time, pain days, bowel emptying, urinary symptoms or a chosen sexual activity.
Reassess contraction and full relaxation without making a lower tone reading the sole treatment goal.
Coordinate medical reassessment if organ symptoms persist; avoid predicting recovery from a fixed visit count.

Evidence and sources

Anatomy, Abdomen and Pelvis: Levator Ani Muscle
2022 · Anatomy reference
Updated October 2022; supports component anatomy and pelvic relationships. Clinical recommendations in this profile use the current pelvic-pain guideline and primary trials.
EAU Guidelines on Chronic Pelvic Pain: Diagnostic Evaluation
2026 · Clinical guideline
Current online chapter verified September 2026; coordinated organ, musculoskeletal and neurological assessment, including pelvic-floor contraction/relaxation. Tenderness cannot exclude organ disease.
EAU Guidelines on Chronic Pelvic Pain: Management
2026 · Clinical guideline
Individualized multidisciplinary care and specialist pelvic-floor treatment. Manual/needle evidence is heterogeneous; prostate-pain shockwave evidence cannot establish efficacy for a levator or obturator trigger point.
Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome
2010 · Randomized trial
157 patients; benefit concentrated in those with levator tenderness on rectal examination. The biofeedback arm had five weekly 30-minute training sessions plus four counselling sessions; benefit was maintained to 12 months. This is a selected chronic anal-pain population, not a universal session promise.
Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness
2012 · Randomized trial
81 women with bladder-pain symptoms for no longer than three years and pelvic-floor tenderness; up to ten 60-minute sessions over 12 weeks. Global response was 59% with targeted internal/external pelvic, hip and abdominal treatment versus 26% with global massage. Separate pain, urgency and frequency changes did not differ significantly; no isolated pelvic-muscle or durable follow-up effect established.
A pilot randomized trial of levator injections versus physical therapy for treatment of pelvic floor myalgia and sexual pain
2015 · Pilot randomized trial
29 women completed; comparable pain improvement after levator-directed injections or physiotherapy at one month after treatment. Sexual-function change favored physiotherapy; injections acted sooner. Small sample and no sham arm.
The Efficacy of Botulinum Toxin A Injection in Pelvic Floor Muscles in Chronic Pelvic Pain Patients: A Double-Blinded Randomised Controlled Trial
2025 · Placebo-controlled randomized trial
94 women with persistent increased pelvic-floor tone despite prior therapy; toxin versus placebo followed by pelvic-floor therapy, follow-up through 26 weeks. Lower resting activity did not produce significantly better primary pain outcomes.
Botulinum toxin for endometriosis-associated chronic pelvic pain: a randomised, double-masked, parallel, phase 2 trial
2026 · Placebo-controlled phase 2 randomized trial
29 analyzed participants with surgically documented endometriosis, persistent pain despite optimized care and palpable pubococcygeus, iliococcygeus or obturator internus spasm. One-month patient-reported benefit favored toxin (11/15 vs 4/14). Small selected sample; later optional open-label injections prevent treating one-year outcomes as randomized evidence.

Associated Trigger Points

Coccygeus
Obterator internus